What we're reading, January 12, 2016: 43,000 people will lose their Affordable Care Act tax credits for failing to file a 2014 tax return; Kentucky's new governor will dismantle the state's health insurance exchange; and deciding whether to get that medical test.
In July 2015, the IRS had warned 710,000 households that they were at risk of losing their Affordable Care Act coverage because they hadn’t filed a tax return. Shortly after, the number of households that hadn’t filed dropped. Now, 43,000 enrollees are losing their tax credits because they still failed to file a tax return for 2014, reported The Hill. As a result, these individuals will bear the full cost of their insurance plans.
Following promises he made on the campaign trail, Kentucky’s new governor, Republican Matt Bevin, is beginning the process to dismantle the state’s health insurance marketplace that was set up under former Democratic Governor Steve Beshear. The Washington Post reported that Beshear had told Bevin that shutting the exchange, which has been one of the most successful state exchanges in the country, would cost $23 million in state money. Shutting down Kynect will not affect the current enrollment period.
While medical tests are becoming more readily available to consumers, we are approaching a time where people need to decide when they want to learn more and when they don’t. Although technology advances are allowing for a proliferation of testing and self-tracking for health, this could lead to wasted money that does more harm than good, according to Bloomberg Business. Experts point out that people often fail to understand that medical interventions carry some risk along with benefit.
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
SGLT2 Inhibitors Show Renal Benefits in HF and CKD as Prescribers Target Uptake Gaps
April 15th 2025Abstracts featured at the National Kidney Foundation Spring Clinical Meeting highlighted the renoprotective benefits of SGLT2 inhibitors in heart failure and diabetic kidney disease while emphasizing the need for strategies to increase their uptake in primary care.
Read More
Health Equity & Access Weekly Roundup: April 14, 2025
April 14th 2025From the potential impact of tariffs to the World Health Organization's year-long campaign launch focused on improving maternal and newborn health and addressing preventable deaths, here's the latest from the Center on Health Equity & Access.
Read More